Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director Declaration

25th Mar 2025 09:00

RNS Number : 9652B
Essentra plc
25 March 2025
 

25 March 2025

 

ESSENTRA PLC

("Essentra")

 

 LISTING RULE 6.4.9 DISCLOSURE

 

Pursuant to Listing Rule 6.4.9(1), Essentra provides the following update:

On 20 February 2025, the board of Laing O'Rourke Construction South Limited, a wholly owned subsidiary of the Laing O'Rourke Corporation Limited, passed a resolution to enter into a creditors' voluntary liquidation and approving the appointment of liquidators. The appointment of the liquidators was confirmed at a meeting of the Company's creditors on 12 March 2025.

Rowan Baker, a director of Essentra PLC, was a director of Laing O'Rourke Construction South Limited until 27 September 2024 when she tendered her resignation as a director.

 

For further information please contact:

Essentra plc

Scott Fawcett, Chief Executive

Emma Reid, Company Secretary

 

Tel: +44 (0)1908 359100

FTI Consulting

Richard Mountain

Ariadna Peretz

[email protected]

Tel: +44 (0)20 3727 1340

LEI: 5493007MOZNA03BVNE96

Notes to Editors

About Essentra plc

Essentra plc is a leading global provider of essential components and solutions, focusing on the manufacture and distribution of plastic injection moulded, vinyl dip moulded and metal items.

Headquartered in the United Kingdom, Essentra's global network extends to 28 countries worldwide and includes c.3,000 employees, 14 manufacturing facilities, 26 distribution centres and 37 sales & service centres serving c.64,000 customers with a rapid supply of low cost but essential products for a variety of applications in industries such as equipment manufacturing, automotive, fabrication, electronics, medical and renewable energy. For further information, please visit www.essentraplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNPKQBKBBKBKNB

Related Shares:

Essentra
FTSE 100 Latest
Value8,658.85
Change-7.27